OverviewSuggest Edit

BiomX discovers and develops microbiome-based therapeutics to prevent and treat cancer, IBD, and topical diseases that stem from dysbiosis. The Company’s microbiome modulation platform uses cutting-edge science, research, and licensed technology.

TypePrivate
Founded2015
HQNess Ziona, IL
Websitebiomx.com

Latest Updates

Employees (est.) (Oct 2020)75
Cybersecurity ratingAMore

Key People/Management at BiomX

Jonathan Solomon

Jonathan Solomon

CEO and Board Member
Russell G. Greig

Russell G. Greig

Chairman of the Board
Assaf Oron

Assaf Oron

CBO
Sailaja Puttagunta

Sailaja Puttagunta

CMO
Merav Bassan

Merav Bassan

CDO
Show more

BiomX Office Locations

BiomX has an office in Ness Ziona
Ness Ziona, IL (HQ)
Pinhas Sapir St 7
Show all (1)

BiomX Financials and Metrics

Summary Metrics

BiomX's latest funding round in February 2019 was reported to be $32 m. In total, BiomX has raised $56 m
Show all financial metrics

BiomX Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

BiomX Online and Social Media Presence

Embed Graph

BiomX News and Updates

Stone Street Group Initiates Coverage On BiomX Inc.

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Stone Street Group has announced it has initiated coverage on BiomX Inc (NYSE: PHGE). The full report can be found here: PHGE Report Key Report Highlights: Chardan Healthcare Acquisition Corp. (NYSE: CHAC, "PHGE"), a special purpose acquisition...

Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

NEW YORK and NESS ZIONA, Israel, Oct. 28, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC), a special purpose acquisition company sponsored by affiliates of Chardan Capital Markets LLC ("Chardan"), announced today the closing of its merger with BiomX Ltd. ("BiomX") a...

BiomX Appoints Merav Bassan as Chief Development Officer

NESS ZIONA, Israel, Oct. 15, 2019 /PRNewswire/ -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced the appointment of Merav Bassan, Ph.D., as Chief Development Officer (CDO). With her extensive experience in developing therapeutics...

Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.

NEW YORK and NESS ZIONA, Israel, Oct. 14, 2019 /PRNewswire/ -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC, "CHAC"), a special purpose acquisition company ("SPAC") sponsored by affiliates of Chardan Capital Markets LLC ("Chardan") and BiomX Ltd. ("BiomX"), a microbiome company...

BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria

NESS ZIONA, Israel, Sept. 30, 2019 /PRNewswire/ -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today presented new data from the company's colorectal cancer synthetic biology program at the Fifth CRI-CIMT-EATI-AACR International Cancer...

BiomX to Present at the Cantor Fitzgerald Global Healthcare Conference

NESS ZIONA, Israel, Sept. 30, 2019 /PRNewswire/ -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced that BiomX's Chief Executive Officer, Jonathan Solomon, will present at the Cantor Fitzgerald Global Healthcare Conference in New...
Show more

BiomX Blogs

BiomX to Present and Conduct 1×1 Investor Meetings at the Oppenheimer Fall Life Sciences & MedTech Summit on September 21-23, 2020

Oppenheimer Fall Life Sciences & MedTech Summit The post BiomX to Present and Conduct 1×1 Investor Meetings at the Oppenheimer Fall Life Sciences & MedTech Summit on September 21-23, 2020 appeared first on BiomX.

BiomX to Present and Conduct 1×1 Investor Meetings at the Cantor Virtual Global Healthcare Conference on September 15-17, 2020

Cantor Virtual Global Healthcare Conference The post BiomX to Present and Conduct 1×1 Investor Meetings at the Cantor Virtual Global Healthcare Conference on September 15-17, 2020 appeared first on BiomX.

BiomX to Present and Conduct 1×1 Investor Meetings the H.C. Wainwright 22nd Annual Global Investment Conference on September 12-16, 2020

Investor Meetings the H.C. Wainwright 22nd Annual Global Investment Conference The post BiomX to Present and Conduct 1×1 Investor Meetings the H.C. Wainwright 22nd Annual Global Investment Conference on September 12-16, 2020 appeared first on BiomX.

BiomX CMO, Sailaja Puttagunta to Present at Bacteriophage Therapy Summit August 28, 2020

Access Bacteriophage Therapy Summit agenda and event website here The post BiomX CMO, Sailaja Puttagunta to Present at Bacteriophage Therapy Summit August 28, 2020 appeared first on BiomX.

BiomX Reports Second Quarter 2020 Financial Results and Provides Business Update

– Expect to initiate Phase 1a clinical study of BX002 for the treatment of IBD in the third quarter of 2020; pharmacokinetics results expected by the end of 2020 – On track for Phase 2 cosmetic clinical study of BX001 in acne first quarter of 2021 – Cash and equivalents of $70.6 million expected to …

BiomX to Report Second Quarter 2020 Financial Results on Aug. 13, 2020

The post BiomX to Report Second Quarter 2020 Financial Results on Aug. 13, 2020 appeared first on BiomX.
Show more

BiomX Frequently Asked Questions

  • When was BiomX founded?

    BiomX was founded in 2015.

  • Who are BiomX key executives?

    BiomX's key executives are Jonathan Solomon, Russell G. Greig and Assaf Oron.

  • How many employees does BiomX have?

    BiomX has 75 employees.

  • Who are BiomX competitors?

    Competitors of BiomX include PushDoctor, Figure 1 and Artemis Health.

  • Where is BiomX headquarters?

    BiomX headquarters is located at Pinhas Sapir St 7, Ness Ziona.

  • Where are BiomX offices?

    BiomX has an office in Ness Ziona.

  • How many offices does BiomX have?

    BiomX has 1 office.